Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Preusser

Showing results (421-430 of 467) with videos related to

Pageof 47
Sort By:
Neuro-Oncology|June 24, 2024
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?Martin J van den Bent, Pim J French, Daniel Brat, et al.
Neuro-Oncology|November 22, 2024
European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selectionFelix Sahm, Luca Bertero, Sebastian Brandner, et al.
Neuro-Oncology|June 9, 2026
BRAF-altered glioma in adults and children: A Society for Neuro-Oncology (SNO) and European Society for Neuro-Oncology (EANO) consensus review on clinical management and future directionsKarisa C Schreck, Macarena I de la Fuente, Mary Jane Lim Fat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 29, 2023
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in AdultsPatrick Y Wen, Martin van den Bent, Gilbert Youssef, et al.
Molecular Cancer Research : MCR|January 14, 2021
Identification and Characterization of Cancer Cells That Initiate Metastases to the Brain and Other OrgansAnna S Berghoff, Yunxiang Liao, Matthia A Karreman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 17, 2025
Clinical potential of [<sup>18</sup>F]FET PET in patients with circumscribed astrocytic gliomaJan-Michael Werner, Maximilian J Mair, Michael M Wollring, et al.
Acta Neuropathologica|October 8, 2013
AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistryFelix Sahm, Juliane Bissel, Christian Koelsche, et al.
Neuro-Oncology Practice|August 15, 2025
Core Outcome Sets for Meningioma In Clinical studies (COSMIC): An international patient and healthcare professional consensus for research studiesChristopher P Millward, Terri S Armstrong, Sabrina Bell, et al.
Neuro-Oncology|March 19, 2024
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trialPatrick Roth, Thierry Gorlia, Jaap C Reijneveld, et al.
Nature Medicine|May 9, 2025
RANO criteria for response assessment of brain metastases based on amino acid PET imagingNathalie L Albert, Norbert Galldiks, Benjamin M Ellingson, et al.
Pageof 47

Showing results (421-430 of 467) with videos related to

Sort By:
Pageof 47
Neuro-Oncology|June 24, 2024
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?Martin J van den Bent, Pim J French, Daniel Brat, et al.
Neuro-Oncology|November 22, 2024
European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selectionFelix Sahm, Luca Bertero, Sebastian Brandner, et al.
Neuro-Oncology|June 9, 2026
BRAF-altered glioma in adults and children: A Society for Neuro-Oncology (SNO) and European Society for Neuro-Oncology (EANO) consensus review on clinical management and future directionsKarisa C Schreck, Macarena I de la Fuente, Mary Jane Lim Fat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 29, 2023
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in AdultsPatrick Y Wen, Martin van den Bent, Gilbert Youssef, et al.
Molecular Cancer Research : MCR|January 14, 2021
Identification and Characterization of Cancer Cells That Initiate Metastases to the Brain and Other OrgansAnna S Berghoff, Yunxiang Liao, Matthia A Karreman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 17, 2025
Clinical potential of [<sup>18</sup>F]FET PET in patients with circumscribed astrocytic gliomaJan-Michael Werner, Maximilian J Mair, Michael M Wollring, et al.
Acta Neuropathologica|October 8, 2013
AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistryFelix Sahm, Juliane Bissel, Christian Koelsche, et al.
Neuro-Oncology Practice|August 15, 2025
Core Outcome Sets for Meningioma In Clinical studies (COSMIC): An international patient and healthcare professional consensus for research studiesChristopher P Millward, Terri S Armstrong, Sabrina Bell, et al.
Neuro-Oncology|March 19, 2024
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trialPatrick Roth, Thierry Gorlia, Jaap C Reijneveld, et al.
Nature Medicine|May 9, 2025
RANO criteria for response assessment of brain metastases based on amino acid PET imagingNathalie L Albert, Norbert Galldiks, Benjamin M Ellingson, et al.
Pageof 47